The nation’s highest court has until midnight Eastern Time (0400 GMT Thursday) to decide how it will handle the most significant abortion case since it tossed out the constitutional right to the procedure last year.

The panel can rule in any number of ways, and abortion rights and anti-abortion activists — as well as millions of Americans — are on tenterhooks waiting to see how the conservative-dominated court proceeds in the latest case involving women’s reproductive rights.

The case stems from a ruling this month by a US District Court judge in Texas that would have banned mifepristone, which was approved by the Food and Drug Administration in 2000 and accounts for more than half of all abortions in the United States.

An appeals court blocked a ban on the pill, but imposed tough restrictions on access, after which the baton was handed to the Supreme Court.

The Supreme Court, where conservatives wield a 6-3 majority, on Friday temporarily stayed the lower court rulings as it weighs what to do next.

The Supreme Court could decide to freeze the lower court rulings pending an appeal from the Justice Department and the mifepristone manufacturer Danco Laboratories.

It could also allow the rulings restricting access to the abortion pill to take effect while the appeals play out at the appellate level.

The court could also decide to hear arguments in the case itself on an expedited basis.

Complicating the case even further is a ruling by a separate federal court in Washington state that said access to mifepristone should be maintained.

Since the Supreme Court overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century, 13 states have banned abortion and it has been severely restricted in others.

– ‘Clear choice’ –

Democratic Representative Katherine Clark said Wednesday that the court faces a “clear choice.”

“Uphold legal and scientific fact or capitulate to MAGA extremism,” Clark said in a reference to former Republican president Donald Trump’s “Make America Great Again” slogan.

“This case marks just the latest assault in the MAGA crusade on reproductive freedom,” Clark told reporters. “Republicans have one goal — a nationwide abortion ban.”

Opposition to the legal attack on the abortion pill is being spearheaded by the Justice Department, which argued that the initial conservative federal judge’s ruling was based on a “deeply misguided assessment” of the pill’s safety.

Mifepristone is one component of a two-drug regimen that can be used through the first 10 weeks of pregnancy. It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.

The appellate court, while striking down the ban on mifepristone, restricted its use to seven weeks of pregnancy, down from 10, and prohibited distribution by mail.

In a filing to the court on Tuesday, the anti-abortion coalition that first brought the case against the FDA repeated their controversial claims that the drug was unsafe.

The coalition said the FDA and the distributor of mifepristone had “brazenly flouted the law and applicable regulations … and continually placed politics above women’s health.”

Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure — or ban it outright.

The post US Supreme Court to weigh in on abortion pill ban first appeared on MegaIcon Magazine.

The post US Supreme Court to weigh in on abortion pill ban appeared first on MegaIcon Magazine.

Moderna Asks FDA to OK Omicron-Specific Shot of Moderna COVID-19 vaccine rests on a table at an inoculation station next to Jackson State University in Jackson, Miss., Tuesday, July 19, 2022. (AP Photo/Rogelio V. Solis)

A vial of the Moderna COVID-19 vaccine sits on a table at a vaccination station near Jackson State University in Jackson, Miss., on July 19, 2022. (AP Photo/Rogelio V. Solis)(AP Photo/Rogelio V. Solis)

The company on Tuesday said it completed its application for an emergency use authorization for the shot for adults ages 18 and older.

“We have worked closely with the FDA to ensure that Americans will have access to Moderna’s updated, bivalent booster, which, if authorized, may offer higher, broader and more durable protection against COVID-19 compared to the currently authorized booster,” Moderna CEO Stéphane Bancel said in a statement.

If authorized, the shots would be ready to ship in September, the company said.

The announcement comes a day after Pfizer completed an application for its updated booster for people ages 12 and older.
Political Cartoons on the Economy

U.S. health officials have pushed for vaccine makers to update their shots, citing waning immunity paired with rapidly emerging coronavirus variants as concerns.

The BA.4 and BA.5 subvariants are currently responsible for the vast majority of new infections in the U.S. Officials hope that updated shots will provide better protection against infection.

The Biden administration has been gearing up for a fall vaccination campaign with the updated shots. Ashish Jha, the White House COVID-19 response coordinator, said last week that the shots will be available to teens and adults “in a few short weeks,” adding that they should “work much better at preventing infection transmission and serious illness” than the current vaccines.

But it is unclear just how many Americans will be willing to roll up their sleeves for another shot, considering the majority of Americans are undervaccinated and only a third of people ages 50 and older who are eligible for a second coronavirus booster shot have gotten one.

The post Moderna Asks FDA to Authorize Omicron-Specific COVID-19 Booster Shot first appeared on MegaIcon Magazine.

The post Moderna Asks FDA to Authorize Omicron-Specific COVID-19 Booster Shot appeared first on MegaIcon Magazine.